v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss) $ 15,651 $ (43,665) $ 18,691 $ (87,911)  
Noncash Reduction of Prior Period Medical Expense     (56,000) 0  
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Depreciation and amortization 21,044 21,083 42,118 42,135  
Premium deficiency reserve (8,659) (5,967) (13,374) (12,929)  
Paid in-kind interest expense     14,710 10,619  
Amortization of original issue discount and debt issuance costs     3,403 402  
Equity-based compensation     1,917 3,271  
Deferred income taxes     478 0  
Loss on asset sale and disposal     127 0  
Mark-to-market adjustment of stock warrants and purchased put option 16,366 (2,002) 16,036 (5,324)  
Changes in operating assets and liabilities:          
Health plan receivable     (27,173) 27,803  
Clinic fees, insurance, and other receivable     (5,975) (3,625)  
Prepaid expenses and other current assets     (9,187) (1,747)  
Other long-term assets     5,039 (14,464)  
Accounts payable, accrued expenses, and other current liabilities     (3,597) 6,200  
Accrued payroll     471 (1,560)  
Health plan settlements payable     (44,182) (13,694)  
Claims payable     (32,714) 948  
Operating lease liability     (169) (223)  
Net cash used in operating activities     (89,381) (50,099)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Other, net     (251) 0  
Proceeds from asset sale       50  
Net cash provided by (used in) investing activities     (251) 50  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from long-term debt, net of original issue discount     27,000 45,000  
Proceeds from short-term debt     1,044 1,137  
Repayment of short-term and long-term debt     (626) (682)  
Payment of debt issuance costs     (30) (181)  
Proceeds from issuance of preferred stock, net of issuance costs     42,674 0  
Net cash provided by financing activities     15,961 0  
Payment of tax withholdings upon settlement of restricted stock unit awards     (4) 0  
Net cash provided by financing activities     86,019 45,274  
Net change in cash and restricted cash     (3,613) (4,775)  
Cash and restricted cash, beginning of period     25,807 44,102 $ 44,102
Cash and restricted cash, end of period 22,194 39,327 22,194 39,327 25,807
Debt Conversion, Converted Instrument, Amount     195,118 0  
Reconciliation of cash and restricted cash:          
Cash 21,272 38,581 21,272 38,581 25,012
Restricted cash 922 746 922 746 795
Total cash and restricted cash $ 22,194 $ 39,327 $ 22,194 $ 39,327 $ 25,807